BioCentury
ARTICLE | Company News

Tracleer cleared in Canada

December 3, 2001 8:00 AM UTC

Canada granted marketing approval to Actelion (SWX:ATLN) for its Tracleer bosentan for pulmonary arterial hypertension (PAH). The product was approved in the U.S. last month, and is under review in th...